Reuters logo
BRIEF-Voyager Therapeutics reports Q3 GAAP loss per share $0.89
November 2, 2017 / 8:35 PM / 15 days ago

BRIEF-Voyager Therapeutics reports Q3 GAAP loss per share $0.89

Nov 2 (Reuters) - Voyager Therapeutics Inc

* Voyager Therapeutics Inc reports third quarter 2017 financial results and corporate highlights

* Q3 GAAP loss per share $0.89

* Q3 earnings per share view $-0.72 -- Thomson Reuters I/B/E/S

* Voyager Therapeutics Inc - ‍total cash, cash equivalents, and marketable debt securities as of september 30, 2017 were $125.6 million​

* Voyager Therapeutics Inc - ‍continues to expect to end 2017 with total cash, cash equivalents, and marketable debt securities of about $90 million to $100 million​

* Voyager Therapeutics Inc - ‍existing cash, cash equivalents, marketable debt securities will be sufficient to fund operating expenses and capex requirements into 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below